CLEMENTI, EMILIO GIUSEPPE IGNAZIO
CLEMENTI, EMILIO GIUSEPPE IGNAZIO
Dipartimento di Scienze Biomediche e Cliniche
PPP exposure models for 3‐D orchards considering spraying technologies in Southern Europe
2024 G. Azimonti, P.C. Adell, E. Clementi, K.P. Ferentinos, C.G. Figueroa, M. Grella, M. Luini, P. Marucco, E. Mozzanini, M. Resecco, L. Tosti
Relevance of pharmacogenetic analyses and therapeutic drug monitoring of antidepressants for an individualized treatment of peripartum psychopathology
2024 A. Colombo, R. Cafaro, I. Di Bernardo, M. Mereghetti, L. Cerolini, L. Giacovelli, F. Giorgetti, S. Vanzetto, N. Girone, V. Savasi, I. Cetin, E. Clementi, M.F. Bosi, V. Caterina, B. Dell’Osso
Targeting mitochondrial dynamics to tackle duchenne muscular dystrophy progression
2023 S.R. Casati, O. Gjana, S. Zecchini, M. Giovarelli, E. Clementi, C. Perrotta, C. De Palma
Pharmacogenetic Practice of Anticancer Drugs: Multiple Approaches for an Accurate and Comprehensive Genotyping
2023 C. Montrasio, S. Cheli, E. Clementi
Cryopreserved placental biopsies maintain mitochondrial activity for high-resolution respirometry
2023 M. Giovarelli, A. Serati, S. Zecchini, F. Guelfi, E. Clementi, C. Mando'
On the potential of drug repurposing in dysphagia treatment: New insights from a real-world pharmacovigilance study and a systematic review
2023 V. Battini, S. Rocca, G. Guarnieri, A. Bombelli, M. Gringeri, G. Mosini, M. Pozzi, M. Nobile, S. Radice, E. Clementi, A. Schindler, C. Carnovale, N. Pizzorni
Umbrella Review: Association Between Antipsychotic Drugs and Metabolic Syndrome Hallmarks in Children and Adolescents
2023 C. Carnovale, V. Battini, C. Santoro, M.P. Riccio, S. Carucci, M. Nobile, P. Formisano, C. Bravaccio, A. Zuddas, E. Clementi, M. Pozzi, S. Pisano
The potential effect of metformin on cognitive and other symptom dimensions in patients with schizophrenia and antipsychotic-induced weight gain: a systematic review, meta-analysis, and meta-regression
2023 V. Battini, G. Cirnigliaro, R. Leuzzi, E. Rissotto, G. Mosini, B. Benatti, M. Pozzi, M. Nobile, S. Radice, C. Carnovale, B. Dell'Osso, E. Clementi
Psychiatric and non-psychiatric drugs causing false-positive amphetamines urine test in psychiatric patients: a pharmacovigilance analysis using FAERS
2023 V. Battini, G. Cirnigliaro, L. Giacovelli, M. Boscacci, S. MASSARA MANZO, G. Mosini, G. Guarnieri, M. Gringeri, B. Benatti, E.G.I. Clementi, D. Bernardo, C. Carnovale
Neuroprotective role of plumbagin on eye damage induced by high-sucrose diet in adult fruit fly Drosophila melanogaster
2023 E. Catalani, S. Del Quondam, K. Brunetti, A. Cherubini, S. Bongiorni, A.R. Taddei, S. Zecchini, M. Giovarelli, C. De Palma, C. Perrotta, E. Clementi, G. Prantera, D. Cervia
Exposure to environmental pollutants and attention-deficit/hyperactivity disorder: an overview of systematic reviews and meta-analyses
2023 E. Rosi, A. Crippa, M. Pozzi, S. De Francesco, M. Fioravanti, M. Mauri, M. Molteni, L. Morello, L. Tosti, F. Metruccio, E. Clementi, M. Nobile
Ubrogepant and rimegepant: signal detection using spontaneous reports of adverse events from the Food and Drug Administration Adverse Event Reporting System
2023 V. Battini, C. Carnovale, E. Clementi, M. Sessa
Exploring the underlying mechanisms of drug-induced impulse control disorders: a pharmacovigilance-pharmacodynamic study
2023 M. Fusaroli, V. Giunchi, V. Battini, M. Gringeri, R. Rimondini, M. Menchetti, S. Radice, M. Pozzi, M. Nobile, E. Clementi, F. De Ponti, C. Carnovale, E. Raschi, E. Poluzzi
The potential antidepressant effect of antidiabetic agents: New insights from a pharmacovigilance study based on data from the reporting system databases FAERS and VigiBase
2023 V. Battini, R.P. Van Manen, M. Gringeri, G. Mosini, G. Guarnieri, A. Bombelli, M. Pozzi, M. Nobile, S. Radice, E. Clementi, C. Carnovale
Two Years of Active Pharmacovigilance Surveillance and Therapeutic Reconciliation in Frail Populations: The MEAP 3.0 Study
2023 A. Bombelli, G. Guarnieri, N. Lombardi, M.G. Sullo, E. Spina, G. Crescioli, C. Rafaniello, G. Cicala, V. Marangon, R. Folchino, S. Vecchio, G. Mosini, S. Radice, E. Clementi
Therapeutic Drug Monitoring of Anti-TNFα Inhibitors: A Matter of Cut-Off Ranges
2023 S. Cheli, D. Savino, F. Penagini, G. Zuccotti, G. Zuin, E. Clementi, D. Cattaneo
Updated Considerations for the Immunopharmacological Aspects of the “Talented mRNA Vaccines”
2023 C. Perrotta, C. Fenizia, C. Carnovale, M. Pozzi, D. Trabattoni, D. Cervia, E. Clementi
SRT2104, a new specific SIRT1 activator, promotes muscle recovery enhancing mitochondrial metabolism in DMD
2022 S. Zecchini, S. Casati, L. Mollica, M. Cattaneo, C. Banfi, D. Brunetti, C. Perrotta, E. Clementi, M. Giovarelli, C. De Palma
Impact of Drp1 activation and fission induction in the pathogenesis of DMD progression
2022 S.R. Casati, A. Aleta, S. Zecchini, M. Giovarelli, E. Clementi, C. Perrotta, C. De Palma
Herpes zoster and simplex reactivation following COVID-19 vaccination: new insights from a vaccine adverse event reporting system (VAERS) database analysis
2022 M. Gringeri, V. Battini, G. Cammarata, G. Mosini, G. Guarnieri, C. Leoni, M. Pozzi, S. Radice, E. Clementi, C. Carnovale